{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T07:28:23Z","timestamp":1794814103499,"version":"4.9.1"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173305"],"award-info":[{"award-number":["82173305"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.critrevonc.2025.104745","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:25:07Z","timestamp":1746059107000},"page":"104745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The role and clinical significance of tumor-draining lymph nodes in tumor progression and immunotherapy"],"prefix":"10.1016","volume":"212","author":[{"given":"Qian","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5868-4482","authenticated-orcid":false,"given":"Lian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.critrevonc.2025.104745_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri3442","article-title":"The integration of T cell migration, differentiation and function","volume":"13","author":"Masopust","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2025.104745_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2015.05.003","article-title":"Chemokine-guided cell positioning in the lymph node orchestrates the generation of adaptive immune responses","volume":"36","author":"Lian","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12951-023-01977-1","article-title":"Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions","volume":"21","author":"Li","year":"2023","journal-title":"J. Nanobiotechnology"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104745_bib4","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.tcb.2023.04.001","article-title":"Lymph nodes: at the intersection of cancer treatment and progression","volume":"33","author":"Reticker-Flynn","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"63","key":"10.1016\/j.critrevonc.2025.104745_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg3551","article-title":"Tumor-draining lymph nodes: at the crossroads of metastasis and immunity","volume":"6","author":"du Bois","year":"2021","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med"},{"issue":"17","key":"10.1016\/j.critrevonc.2025.104745_bib7","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N. Engl. J. Med"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104745_bib8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","article-title":"Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial","volume":"17","author":"Seiwert","year":"2016","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104745_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0013","article-title":"Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical KEYNOTE-059 trial","volume":"4","author":"Fuchs","year":"2018","journal-title":"JAMA Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104745_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1200\/JCO.20.01605","article-title":"Five-year outcomes from the randomized, phase iii trials checkmate 017 and 057: nivolumab versus docetaxel in previously treated non-small-cell lung cancer","volume":"39","author":"Borghaei","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"10308","key":"10.1016\/j.critrevonc.2025.104745_bib11","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip","year":"2021","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.critrevonc.2025.104745_bib12","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1056\/NEJMoa1716078","article-title":"Neoadjuvant PD-1 blockade in resectable lung cancer","volume":"378","author":"Forde","year":"2018","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104745_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jama.2023.24735","article-title":"Perioperative toripalimab plus chemotherapy for patients with resectable non-small cell lung cancer: the neotorch randomized clinical trial","volume":"331","author":"Lu","year":"2024","journal-title":"JAMA"},{"issue":"6477","key":"10.1016\/j.critrevonc.2025.104745_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/science.aax0182","article-title":"Neoadjuvant checkpoint blockade for cancer immunotherapy","volume":"367","author":"Topalian","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12967-022-03444-1","article-title":"Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy","volume":"20","author":"Okamura","year":"2022","journal-title":"J. Transl. Med"},{"issue":"17","key":"10.1016\/j.critrevonc.2025.104745_bib16","doi-asserted-by":"crossref","first-page":"9401","DOI":"10.3390\/ijms22179401","article-title":"Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights","volume":"22","author":"Fransen","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104745_bib17","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.4049\/jimmunol.162.10.5838","article-title":"Tumor antigens are constitutively presented in the draining lymph nodes","volume":"162","author":"Marzo","year":"1999","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.immuni.2022.12.002","article-title":"CD8(+) T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor","volume":"56","author":"Prokhnevska","year":"2023","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104745_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic immunity is required for effective cancer immunotherapy","volume":"168","author":"Spitzer","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104745_bib20","first-page":"1098","article-title":"Role of stem cell-like memory T cells in autoimmune diseases","volume":"48","author":"Liu","year":"2023","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104745_bib21","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.immuni.2021.08.026","article-title":"Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1(+) CD8(+) T cells in tumor-draining lymph nodes","volume":"54","author":"Schenkel","year":"2021","journal-title":"Immunity"},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104745_bib22","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","article-title":"The primordial differentiation of tumor-specific memory CD8(+) T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes","volume":"185","author":"Huang","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41392-023-01356-0","article-title":"Tumor-draining lymph node-derived tumor-specific memory CD8(+) T cells: a key player in PD-1\/PD-L1 immunotherapy","volume":"8","author":"Yin","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104745_bib24","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","article-title":"Dendritic cells as shepherds of T cell immunity in cancer","volume":"56","author":"Pittet","year":"2023","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104745_bib25","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.3390\/cancers12102756","article-title":"PD-1 expression by lymph node and intratumoral regulatory T cells is associated with lymph node metastasis in pancreatic cancer","volume":"12","author":"Seifert","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.critrevonc.2025.104745_bib26","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1158\/1078-0432.CCR-10-1073","article-title":"Accumulation of foxp3+\u2009T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients","volume":"16","author":"Deng","year":"2010","journal-title":"Clin. Cancer Res"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104745_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00262-024-03754-x","article-title":"High expression of PD-L1 on conventional dendritic cells in tumour-draining lymph nodes is associated with poor prognosis in oral cancer","volume":"73","author":"Eric","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104745_bib28","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1007\/s00262-023-03472-w","article-title":"Unbiased chemokine receptor screening reveals similar efficacy of lymph node- and tumor-targeted T cell immunotherapy","volume":"72","author":"Pachmayr","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1158\/2326-6066.CIR-16-0113","article-title":"IL4 from T follicular helper cells downregulates antitumor immunity","volume":"5","author":"Shirota","year":"2017","journal-title":"Cancer Immunol. Res"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104745_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1340","article-title":"Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil","volume":"13","author":"Peng","year":"2023","journal-title":"Clin. Transl. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib31","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001455R","article-title":"Crosstalk between head and neck cancer cells and lymphatic endothelial cells promotes tumor metastasis via CXCL5-CXCR2 signaling","volume":"35","author":"Lee","year":"2021","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104745_bib32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/modpathol.2010.227","article-title":"Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis","volume":"24","author":"Mansfield","year":"2011","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104745_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cas.12584","article-title":"Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine","volume":"106","author":"Ohshio","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.critrevonc.2025.104745_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1476-511X-11-21","article-title":"Leptin deficiency-induced obesity affects the density of mast cells in abdominal fat depots and lymph nodes in mice","volume":"11","author":"Altintas","year":"2012","journal-title":"Lipids Health Dis."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104745_bib35","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s00262-012-1276-7","article-title":"Mast cells impair the development of protective anti-tumor immunity","volume":"61","author":"Wasiuk","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104745_bib36","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.3892\/ol.2017.6537","article-title":"Disrupted fibroblastic reticular cells and interleukin-7 expression in tumor draining lymph nodes","volume":"14","author":"Gao","year":"2017","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104745_bib37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/jso.21744","article-title":"Significance of lymphangiogenesis in primary tumor and draining lymph nodes during lymphatic metastasis of pancreatic head cancer","volume":"102","author":"Kurahara","year":"2010","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-9966-31-3","article-title":"Inhibition of dendritic cell migration by transforming growth factor-\u03b21 increases tumor-draining lymph node metastasis","volume":"31","author":"Imai","year":"2012","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104745_bib39","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2025.104745_bib40","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fimmu.2017.00358","article-title":"Human melanoma-derived extracellular vesicles regulate dendritic cell maturation","volume":"8","author":"Maus","year":"2017","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.gpb.2019.05.005","article-title":"Genome-wide 5-hydroxymethylcytosine profiling analysis identifies MAP7D1 as a novel regulator of lymph node metastasis in breast cancer","volume":"19","author":"Wu","year":"2021","journal-title":"Genom. Proteom. Bioinforma."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40792-017-0309-z","article-title":"Ascending colon cancer with synchronous external iliac and inguinal lymph node metastases but without regional lymph node metastasis: a case report and brief literature review","volume":"3","author":"Kitano","year":"2017","journal-title":"Surg. Case Rep."},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104745_bib43","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.12998\/wjcc.v10.i23.8262","article-title":"Primary ascending colon cancer accompanying skip metastases in left shoulder skin and left neck lymph node: a case report","volume":"10","author":"Zhou","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.critrevonc.2025.104745_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.733800","article-title":"Control of dendritic cell function within the tumour microenvironment","volume":"13","author":"Gupta","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2025.104745_bib45","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1479-5876-11-242","article-title":"Spatial organization of dendritic cells within tumor draining lymph nodes impacts clinical outcome in breast cancer patients","volume":"11","author":"Chang","year":"2013","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.critrevonc.2025.104745_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216985","article-title":"Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling","volume":"595","author":"Agorku","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/1878-0261.13047","article-title":"Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression","volume":"16","author":"Rye","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104745_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.864497","article-title":"Effector Memory T Cells and CD45RO+\u2009Regulatory T Cells in Metastatic vs. Non-Metastatic Lymph Nodes in Lung Cancer Patients","volume":"13","author":"Kwiecie\u0144","year":"2022","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12967-023-04154-y","article-title":"Functional status and spatial architecture of tumor-infiltrating CD8+\u2009T cells are associated with lymph node metastases in non-small cell lung cancer","volume":"21","author":"Yang","year":"2023","journal-title":"J. Transl. Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104745_bib50","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","article-title":"Dynamic CD8(+) T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes","volume":"186","author":"Rahim","year":"2023","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104745_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111171","article-title":"During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodes","volume":"40","author":"Pylaeva","year":"2022","journal-title":"Cell Rep."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104745_bib52","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","article-title":"Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy","volume":"20","author":"Taube","year":"2014","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104745_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100884","article-title":"Heterogeneous expression of predictive biomarkers PD-L1 and TIGIT in non-mucinous lung adenocarcinoma and corresponding lymph node metastasis: a challenge for clinical biomarker testing","volume":"38","author":"Kolb","year":"2023","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib54","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1830513","article-title":"Single-cell analysis reveals immune modulation and metabolic switch in tumor-draining lymph nodes","volume":"9","author":"Li","year":"2020","journal-title":"Oncoimmunology"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104745_bib55","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/s41551-021-00766-1","article-title":"Solid stress impairs lymphocyte infiltration into lymph-node metastases","volume":"5","author":"Jones","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104745_bib56","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","article-title":"The PD-1\/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes","volume":"38","author":"Dammeijer","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib57","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1038\/s41467-022-31941-w","article-title":"Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC","volume":"13","author":"Saddawi-Konefka","year":"2022","journal-title":"Nat. Commun."},{"issue":"7528","key":"10.1016\/j.critrevonc.2025.104745_bib58","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2025.104745_bib59","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2147\/PPA.S235430","article-title":"Analysis of patient preferences in lung cancer - estimating acceptable tradeoffs between treatment benefit and side effects","volume":"14","author":"Janssen","year":"2020","journal-title":"Patient Prefer Adherence"},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104745_bib60","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124507","article-title":"Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy","volume":"3","author":"Fransen","year":"2018","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104745_bib61","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00262-020-02792-5","article-title":"Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC","volume":"70","author":"O'Melia","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib62","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/s41467-023-38014-6","article-title":"Temperature sensitive liposome based cancer nanomedicine enables tumour lymph node immune microenvironment remodelling","volume":"14","author":"Fu","year":"2023","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104745_bib63","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","article-title":"Clonal replacement of tumor-specific T cells following PD-1 blockade","volume":"25","author":"Yost","year":"2019","journal-title":"Nat. Med"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104745_bib64","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s43018-020-0075-x","article-title":"PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer","volume":"1","author":"Oh","year":"2020","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib65","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1940673","article-title":"Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma","volume":"10","author":"Choi","year":"2021","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104745_bib66","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132286","article-title":"Multipanel mass cytometry reveals anti-PD-1 therapy-mediated B and T cell compartment remodeling in tumor-draining lymph nodes","volume":"5","author":"Ho","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.critrevonc.2025.104745_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584423","article-title":"Tumor infiltrating effector memory antigen-specific CD8(+) T cells predict response to immune checkpoint therapy","volume":"11","author":"Principe","year":"2020","journal-title":"Front Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104745_bib68","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","article-title":"A transcriptionally and functionally distinct PD-1(+) CD8(+) T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade","volume":"24","author":"Thommen","year":"2018","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib69","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40164-023-00401-6","article-title":"\"Major pathologic response\" in lymph nodes: a modified nodal classification for non-small cell lung cancer patients treated with neoadjuvant immunochemotherapy","volume":"12","author":"Deng","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104745_bib70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2010.05919.x","article-title":"The role of the PD-1 pathway in autoimmunity and peripheral tolerance","volume":"1217","author":"Fife","year":"2011","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104745_bib71","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1158\/2326-6066.CIR-14-0104","article-title":"Cytotoxic T lymphocyte antigen-4 blockade enhances antitumor immunity by stimulating melanoma-specific T-cell motility","volume":"2","author":"Pentcheva-Hoang","year":"2014","journal-title":"Cancer Immunol. Res"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104745_bib72","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104745_bib73","doi-asserted-by":"crossref","first-page":"195","DOI":"10.14740\/wjon1489","article-title":"Pathological Responses of the Primary Tumor and Locoregional Lymph Nodes After Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Cancer","volume":"13","author":"Huang","year":"2022","journal-title":"World J. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104745_bib74","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005160","article-title":"Response of primary tumor and lymph node in non-small cell lung cancer after neoadjuvant immunotherapy: a pooled analysis","volume":"10","author":"Zhai","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104745_bib75","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5230\/jgc.2020.20.e29","article-title":"Preoperative therapy regimen influences the incidence and implication of nodal downstaging in patients with gastric cancer","volume":"20","author":"Stark","year":"2020","journal-title":"J. Gastric Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104745_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110331","article-title":"PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes","volume":"38","author":"Nagasaki","year":"2022","journal-title":"Cell Rep."},{"issue":"73","key":"10.1016\/j.critrevonc.2025.104745_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn8097","article-title":"Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic T(reg) reduction and effector T cell activation","volume":"7","author":"van Pul","year":"2022","journal-title":"Sci. Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104745_bib78","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1021\/acs.biomac.0c00518","article-title":"pH-responsive biomimetic polymeric micelles as lymph node-targeting vaccines for enhanced antitumor immune responses","volume":"21","author":"Yang","year":"2020","journal-title":"Biomacromolecules"},{"issue":"39","key":"10.1016\/j.critrevonc.2025.104745_bib79","doi-asserted-by":"crossref","first-page":"33532","DOI":"10.1021\/acsami.8b10081","article-title":"Immune adjuvant targeting micelles allow efficient dendritic cell migration to lymph nodes for enhanced cellular immunity","volume":"10","author":"Yang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"32","key":"10.1016\/j.critrevonc.2025.104745_bib80","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204078119","article-title":"Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity","volume":"119","author":"Backlund","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2025.104745_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.803090","article-title":"S-540956, a CpG oligonucleotide annealed to a complementary strand with an amphiphilic chain unit, acts as a potent cancer vaccine adjuvant by targeting draining lymph nodes","volume":"12","author":"Nakagawa","year":"2021","journal-title":"Front Immunol."},{"issue":"34","key":"10.1016\/j.critrevonc.2025.104745_bib82","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207841119","article-title":"Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104745_bib83","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.immuni.2021.08.019","article-title":"Resident memory CD8(+) T cells in regional lymph nodes mediate immunity to metastatic melanoma","volume":"54","author":"Molodtsov","year":"2021","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104745_bib84","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00262-012-1290-9","article-title":"Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma","volume":"61","author":"Alb","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104745_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101623","article-title":"Galunisertib drives treg fragility and promotes dendritic cell-mediated immunity against experimental lymphoma","volume":"23","author":"Hira","year":"2020","journal-title":"iScience"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104745_bib86","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00262-019-02330-y","article-title":"Unlocking the therapeutic potential of primary tumor-draining lymph nodes","volume":"68","author":"Rotman","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"issue":"27","key":"10.1016\/j.critrevonc.2025.104745_bib87","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.12998\/wjcc.v10.i27.9743","article-title":"Successful treatment of stage IIIB intrahepatic cholangiocarcinoma using neoadjuvant therapy with the PD-1 inhibitor camrelizumab: a case report","volume":"10","author":"Zhu","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.critrevonc.2025.104745_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102793","article-title":"Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome","volume":"56","author":"Venet","year":"2020","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104745_bib89","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.15252\/emmm.201606914","article-title":"TGF-\u03b21 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB","volume":"9","author":"Huang","year":"2017","journal-title":"EMBO Mol. Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104745_bib90","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1245\/s10434-015-5075-1","article-title":"Adjuvant therapy improves survival for T2N0 gastric cancer patients with sub-optimal lymphadenectomy","volume":"23","author":"In","year":"2016","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104745_bib91","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41416-023-02372-1","article-title":"Immune microenvironment and lymph node yield in colorectal cancer","volume":"129","author":"Lee","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104745_bib92","doi-asserted-by":"crossref","first-page":"90","DOI":"10.21037\/atm.2019.12.118","article-title":"Clinical significance and prognosis of supraclavicular lymph node metastasis in patients with thoracic esophageal cancer","volume":"8","author":"Wang","year":"2020","journal-title":"Ann. Transl. Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104745_bib93","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/IGC.0000000000000043","article-title":"Pelvic lymphadenectomy improves survival in patients with cervical cancer with low-volume disease in the sentinel node: a retrospective multicenter cohort study","volume":"24","author":"Zaal","year":"2014","journal-title":"Int J. Gynecol. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104745_bib94","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejca.2022.04.002","article-title":"Increased survival in non-endometrioid endometrial cancer after introducing lymphadenectomy and tailoring radiotherapy - a population-based cohort study","volume":"169","author":"\u00c5kesson","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104745_bib95","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1245\/s10434-021-09667-8","article-title":"Rates, predictors, and outcomes of portal lymphadenectomy for resectable gallbladder cancer","volume":"28","author":"Kemp Bohan","year":"2021","journal-title":"Ann. Surg. Oncol."},{"issue":"33","key":"10.1016\/j.critrevonc.2025.104745_bib96","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1111\/1759-7714.15122","article-title":"Complete dissection of right paratracheal lymph nodes (stations 2R and 4R) is critical to improve the prognosis of lung cancer patients: A retrospective cohort study","volume":"14","author":"Zhao","year":"2023","journal-title":"Thorac. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib97","first-page":"238","article-title":"Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study","volume":"110","author":"Deng","year":"2024","journal-title":"Int J. Surg."},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104745_bib98","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N. Engl. J. Med"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104745_bib99","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1808424","article-title":"A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib100","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/curroncol29010027","article-title":"Lymph Node Dissection Is a Risk Factor for Short-Term Cough after Pulmonary Resection","volume":"29","author":"Wu","year":"2022","journal-title":"Curr. Oncol."},{"issue":"20","key":"10.1016\/j.critrevonc.2025.104745_bib101","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1158\/1078-0432.CCR-17-3427","article-title":"Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy","volume":"24","author":"Marciscano","year":"2018","journal-title":"Clin. Cancer Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104745_bib102","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(23)00541-7","article-title":"Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study","volume":"25","author":"Shitara","year":"2024","journal-title":"Lancet Oncol."},{"issue":"21","key":"10.1016\/j.critrevonc.2025.104745_bib103","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104745_bib104","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann. Surg."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104745_bib105","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","article-title":"Prolonged survival in stage iii melanoma with ipilimumab adjuvant therapy","volume":"375","author":"Eggermont","year":"2016","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104745_bib106","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41577-024-01013-9","article-title":"Lymph node resection does not impair cancer immunotherapy responses","volume":"24","author":"Baldran-Groves","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104745_bib107","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1470-2045(22)00518-6","article-title":"Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS\/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial","volume":"23","author":"O'Brien","year":"2022","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104745_bib108","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.annonc.2023.07.001","article-title":"Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial","volume":"34","author":"Felip","year":"2023","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104745_bib109","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S2468-1253(24)00156-0","volume":"9","author":"Kang","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104745_bib110","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa2215530","article-title":"Perioperative nivolumab and chemotherapy in stage III non-small-cell lung cancer","volume":"389","author":"Provencio","year":"2023","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.critrevonc.2025.104745_bib111","article-title":"Perioperative toripalimab +\u2009platinum-doublet chemotherapy vs chemotherapy in resectable stage II\/III non-small cell lung cancer (NSCLC): interim event-free survival (EFS) analysis of the phase III NEOTORCH study","author":"Lu","year":"2023","journal-title":"ASCO Annu. Meet."},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104745_bib112","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative durvalumab for resectable non-small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N. Engl. J. Med"},{"issue":"10459","key":"10.1016\/j.critrevonc.2025.104745_bib113","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(24)01756-2","article-title":"Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"404","author":"Spicer","year":"2024","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104745_bib114","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non-small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N. Engl. J. Med"},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104745_bib115","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJMoa2311926","article-title":"Perioperative nivolumab in resectable lung cancer","volume":"390","author":"Cascone","year":"2024","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104745_bib116","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S2213-2600(24)00269-8","article-title":"Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial","volume":"13","author":"Yue","year":"2025","journal-title":"Lancet Respir. Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104745_bib117","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1200\/JCO.23.00975","article-title":"Perioperative atezolizumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable esophagogastric cancer: interim results from the randomized, multicenter, phase II\/III DANTE\/IKF-s633 Trial","volume":"42","author":"Lorenzen","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104745_bib118","first-page":"S1315","article-title":"LBA73 Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC\/GEJC): Interim results of the global, phase III MATTERHORN study","volume":"34","author":"Janjigian","year":"2023","journal-title":"Abstr. Book ESMO Congr. 2023, 20 - 24 Oct. 2023. Ann. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104745_bib119","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1200\/JCO.24.00795","article-title":"Pathologic response of phase III study: perioperative camrelizumab plus rivoceranib and chemotherapy versus chemotherapy for locally advanced gastric cancer (DRAGON IV\/CAP 05)","volume":"43","author":"Li","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104745_bib120","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1177\/02841851231179178","article-title":"Imaging evaluation of para-aortic lymph nodes in cervical cancer","volume":"64","author":"Zhu","year":"2023","journal-title":"Acta Radio."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib121","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s40792-021-01352-y","article-title":"Postoperative recurrence with right cervical lymph node metastasis in hepatocellular carcinoma: a case report","volume":"7","author":"Tanoue","year":"2021","journal-title":"Surg. Case Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104745_bib122","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/0972-3919.152982","article-title":"Missing sentinel lymph node in cutaneous melanoma","volume":"30","author":"Dellavedova","year":"2015","journal-title":"Indian J. Nucl. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib123","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1186\/s12885-021-08688-6","article-title":"Diagnostic utility of metabolic parameters on FDG PET\/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer","volume":"21","author":"Nakanishi","year":"2021","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104745_bib124","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/SLA.0b013e3181c0e92a","article-title":"Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study","volume":"251","author":"Veronesi","year":"2010","journal-title":"Ann. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104745_bib125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamasurg.2021.7554","article-title":"Representativeness of the index lymph node for total nodal basin in pathologic response assessment after neoadjuvant checkpoint inhibitor therapy in patients with stage III melanoma","volume":"157","author":"Reijers","year":"2022","journal-title":"JAMA Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104745_bib126","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamasurg.2019.6033","article-title":"Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Laparoscopic Radical Gastrectomy in Patients With Gastric Cancer: A Randomized Clinical Trial","volume":"155","author":"Chen","year":"2020","journal-title":"JAMA Surg."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104745_bib127","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/s43018-024-00795-0","article-title":"AI-assisted detection of lymph node metastases safely reduces costs and time","volume":"5","year":"2024","journal-title":"Nat. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104745_bib128","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.pathol.2017.06.003","article-title":"Tumour infiltrating lymphocytes are predictors of lymph node metastasis in early gastric cancers","volume":"49","author":"Kim","year":"2017","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib129","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12967-018-1692-3","article-title":"Possibility of avoiding axillary lymph node dissection by immune microenvironment monitoring in preoperative chemotherapy for breast cancer","volume":"16","author":"Takada","year":"2018","journal-title":"J. Transl. Med"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104745_bib130","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12282-020-01079-y","article-title":"Tumor-infiltrating regulatory T cells, CD8\/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer","volume":"27","author":"Solis-Castillo","year":"2020","journal-title":"Breast Cancer"},{"key":"10.1016\/j.critrevonc.2025.104745_bib131","first-page":"57","article-title":"Tumor-draining lymph secretome En route to the regional lymph node in","volume":"12","author":"Mohammed","year":"2020","journal-title":"Breast Cancer Metastas-.-. Breast Cancer (Dove Med Press"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104745_bib132","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jid.2020.03.948","article-title":"PD-1, PD-L1, and BIM as predictors of sentinel lymph node metastasis in primary cutaneous melanoma","volume":"140","author":"Kung","year":"2020","journal-title":"J. Invest Dermatol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104745_bib133","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/cancers13050965","article-title":"Tumour-infiltrating lymphocytes (TILs) and PD-L1 expression correlate with lymph node metastasis, high-grade transformation and shorter metastasis-free survival in patients with acinic cell carcinoma (AciCC) of the salivary glands","volume":"13","author":"Hiss","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"17","key":"10.1016\/j.critrevonc.2025.104745_bib134","doi-asserted-by":"crossref","first-page":"17648","DOI":"10.1002\/cam4.6382","article-title":"Serum soluble immune checkpoint levels predict cervical lymph node metastasis of differentiated thyroid carcinoma patients","volume":"12","author":"Shao","year":"2023","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104745_bib135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4048\/jbc.2015.18.1.63","article-title":"Effectiveness of breast MRI and (18)F-FDG PET\/CT for the preoperative staging of invasive lobular carcinoma versus ductal carcinoma","volume":"18","author":"Jung","year":"2015","journal-title":"J. Breast Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104745_bib136","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jcma.2017.05.014","article-title":"Therapeutic value of lymphadenectomy and adjuvant radiotherapy in uterine corpus confined endometrioid-type cancer","volume":"81","author":"Turan","year":"2018","journal-title":"J. Chin. Med Assoc."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:14:56Z","timestamp":1752711296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":136,"alternative-id":["S1040842825001337"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104745","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role and clinical significance of tumor-draining lymph nodes in tumor progression and immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104745"}}